nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—CYP3A4—bone cancer	0.867	1	CbGaD
Budesonide—Fluocinonide—SMO—bone cancer	0.00347	0.418	CrCbGaD
Budesonide—Hydrocortamate—CYP3A4—bone cancer	0.000491	0.0592	CrCbGaD
Budesonide—Alclometasone—CYP3A4—bone cancer	0.000393	0.0474	CrCbGaD
Budesonide—Flunisolide—CYP3A4—bone cancer	0.000383	0.0462	CrCbGaD
Budesonide—Paramethasone—CYP3A4—bone cancer	0.000378	0.0456	CrCbGaD
Budesonide—Ciclesonide—CYP3A4—bone cancer	0.000372	0.0448	CrCbGaD
Budesonide—Fluorometholone—CYP3A4—bone cancer	0.000369	0.0445	CrCbGaD
Budesonide—Methylprednisolone—CYP3A4—bone cancer	0.000357	0.043	CrCbGaD
Budesonide—Triamcinolone—CYP3A4—bone cancer	0.000301	0.0363	CrCbGaD
Budesonide—Triamcinolone—PTGS2—bone cancer	0.000294	0.0355	CrCbGaD
Budesonide—Infestation—Methotrexate—bone cancer	0.000285	0.00229	CcSEcCtD
Budesonide—Pain—Cisplatin—bone cancer	0.000283	0.00227	CcSEcCtD
Budesonide—Dysuria—Epirubicin—bone cancer	0.00028	0.00225	CcSEcCtD
Budesonide—Abdominal distension—Doxorubicin—bone cancer	0.000278	0.00224	CcSEcCtD
Budesonide—Conjunctivitis—Methotrexate—bone cancer	0.000277	0.00222	CcSEcCtD
Budesonide—Influenza—Doxorubicin—bone cancer	0.000277	0.00222	CcSEcCtD
Budesonide—Pollakiuria—Epirubicin—bone cancer	0.000276	0.00222	CcSEcCtD
Budesonide—Feeling abnormal—Cisplatin—bone cancer	0.000273	0.00219	CcSEcCtD
Budesonide—Prednisone—CYP3A4—bone cancer	0.000273	0.0329	CrCbGaD
Budesonide—Weight increased—Epirubicin—bone cancer	0.000272	0.00219	CcSEcCtD
Budesonide—Haematuria—Methotrexate—bone cancer	0.000272	0.00218	CcSEcCtD
Budesonide—Epistaxis—Methotrexate—bone cancer	0.000269	0.00216	CcSEcCtD
Budesonide—Infestation—Epirubicin—bone cancer	0.000267	0.00214	CcSEcCtD
Budesonide—Infestation NOS—Epirubicin—bone cancer	0.000267	0.00214	CcSEcCtD
Budesonide—Bronchitis—Doxorubicin—bone cancer	0.000266	0.00214	CcSEcCtD
Budesonide—Body temperature increased—Cisplatin—bone cancer	0.000262	0.0021	CcSEcCtD
Budesonide—Conjunctivitis—Epirubicin—bone cancer	0.000259	0.00208	CcSEcCtD
Budesonide—Urinary tract infection—Epirubicin—bone cancer	0.000259	0.00208	CcSEcCtD
Budesonide—Dysuria—Doxorubicin—bone cancer	0.000259	0.00208	CcSEcCtD
Budesonide—Haemoglobin—Methotrexate—bone cancer	0.000257	0.00206	CcSEcCtD
Budesonide—Haemorrhage—Methotrexate—bone cancer	0.000256	0.00205	CcSEcCtD
Budesonide—Pollakiuria—Doxorubicin—bone cancer	0.000256	0.00205	CcSEcCtD
Budesonide—Haematuria—Epirubicin—bone cancer	0.000254	0.00204	CcSEcCtD
Budesonide—Pharyngitis—Methotrexate—bone cancer	0.000254	0.00204	CcSEcCtD
Budesonide—Urinary tract disorder—Methotrexate—bone cancer	0.000252	0.00203	CcSEcCtD
Budesonide—Weight increased—Doxorubicin—bone cancer	0.000252	0.00202	CcSEcCtD
Budesonide—Epistaxis—Epirubicin—bone cancer	0.000251	0.00202	CcSEcCtD
Budesonide—Prednisolone—CYP3A4—bone cancer	0.000251	0.0303	CrCbGaD
Budesonide—Urethral disorder—Methotrexate—bone cancer	0.000251	0.00201	CcSEcCtD
Budesonide—Sinusitis—Epirubicin—bone cancer	0.00025	0.00201	CcSEcCtD
Budesonide—Infestation NOS—Doxorubicin—bone cancer	0.000247	0.00198	CcSEcCtD
Budesonide—Infestation—Doxorubicin—bone cancer	0.000247	0.00198	CcSEcCtD
Budesonide—Visual impairment—Methotrexate—bone cancer	0.000246	0.00198	CcSEcCtD
Budesonide—Betamethasone—CYP3A4—bone cancer	0.000246	0.0297	CrCbGaD
Budesonide—Hypersensitivity—Cisplatin—bone cancer	0.000244	0.00196	CcSEcCtD
Budesonide—Betamethasone—PTGS2—bone cancer	0.000241	0.0291	CrCbGaD
Budesonide—Haemoglobin—Epirubicin—bone cancer	0.00024	0.00193	CcSEcCtD
Budesonide—Rhinitis—Epirubicin—bone cancer	0.00024	0.00193	CcSEcCtD
Budesonide—Conjunctivitis—Doxorubicin—bone cancer	0.00024	0.00193	CcSEcCtD
Budesonide—Urinary tract infection—Doxorubicin—bone cancer	0.00024	0.00193	CcSEcCtD
Budesonide—Haemorrhage—Epirubicin—bone cancer	0.000239	0.00192	CcSEcCtD
Budesonide—Eye disorder—Methotrexate—bone cancer	0.000239	0.00192	CcSEcCtD
Budesonide—Asthenia—Cisplatin—bone cancer	0.000237	0.00191	CcSEcCtD
Budesonide—Pharyngitis—Epirubicin—bone cancer	0.000237	0.00191	CcSEcCtD
Budesonide—Cardiac disorder—Methotrexate—bone cancer	0.000237	0.00191	CcSEcCtD
Budesonide—Urinary tract disorder—Epirubicin—bone cancer	0.000236	0.0019	CcSEcCtD
Budesonide—Oedema peripheral—Epirubicin—bone cancer	0.000236	0.00189	CcSEcCtD
Budesonide—Haematuria—Doxorubicin—bone cancer	0.000235	0.00189	CcSEcCtD
Budesonide—Connective tissue disorder—Epirubicin—bone cancer	0.000235	0.00189	CcSEcCtD
Budesonide—Urethral disorder—Epirubicin—bone cancer	0.000235	0.00188	CcSEcCtD
Budesonide—Epistaxis—Doxorubicin—bone cancer	0.000233	0.00187	CcSEcCtD
Budesonide—Angiopathy—Methotrexate—bone cancer	0.000232	0.00186	CcSEcCtD
Budesonide—Sinusitis—Doxorubicin—bone cancer	0.000231	0.00186	CcSEcCtD
Budesonide—Immune system disorder—Methotrexate—bone cancer	0.000231	0.00185	CcSEcCtD
Budesonide—Visual impairment—Epirubicin—bone cancer	0.000231	0.00185	CcSEcCtD
Budesonide—Mediastinal disorder—Methotrexate—bone cancer	0.00023	0.00185	CcSEcCtD
Budesonide—Diarrhoea—Cisplatin—bone cancer	0.000226	0.00182	CcSEcCtD
Budesonide—Alopecia—Methotrexate—bone cancer	0.000226	0.00181	CcSEcCtD
Budesonide—Mental disorder—Methotrexate—bone cancer	0.000224	0.0018	CcSEcCtD
Budesonide—Eye disorder—Epirubicin—bone cancer	0.000224	0.0018	CcSEcCtD
Budesonide—Malnutrition—Methotrexate—bone cancer	0.000223	0.00179	CcSEcCtD
Budesonide—Haemoglobin—Doxorubicin—bone cancer	0.000223	0.00179	CcSEcCtD
Budesonide—Flushing—Epirubicin—bone cancer	0.000222	0.00178	CcSEcCtD
Budesonide—Cardiac disorder—Epirubicin—bone cancer	0.000222	0.00178	CcSEcCtD
Budesonide—Rhinitis—Doxorubicin—bone cancer	0.000222	0.00178	CcSEcCtD
Budesonide—Haemorrhage—Doxorubicin—bone cancer	0.000221	0.00178	CcSEcCtD
Budesonide—Pharyngitis—Doxorubicin—bone cancer	0.00022	0.00176	CcSEcCtD
Budesonide—Urinary tract disorder—Doxorubicin—bone cancer	0.000219	0.00176	CcSEcCtD
Budesonide—Oedema peripheral—Doxorubicin—bone cancer	0.000218	0.00175	CcSEcCtD
Budesonide—Dysgeusia—Methotrexate—bone cancer	0.000218	0.00175	CcSEcCtD
Budesonide—Connective tissue disorder—Doxorubicin—bone cancer	0.000218	0.00175	CcSEcCtD
Budesonide—Angiopathy—Epirubicin—bone cancer	0.000217	0.00174	CcSEcCtD
Budesonide—Urethral disorder—Doxorubicin—bone cancer	0.000217	0.00174	CcSEcCtD
Budesonide—Immune system disorder—Epirubicin—bone cancer	0.000216	0.00174	CcSEcCtD
Budesonide—Mediastinal disorder—Epirubicin—bone cancer	0.000216	0.00173	CcSEcCtD
Budesonide—Back pain—Methotrexate—bone cancer	0.000215	0.00173	CcSEcCtD
Budesonide—Visual impairment—Doxorubicin—bone cancer	0.000213	0.00171	CcSEcCtD
Budesonide—Alopecia—Epirubicin—bone cancer	0.000211	0.0017	CcSEcCtD
Budesonide—Vomiting—Cisplatin—bone cancer	0.00021	0.00169	CcSEcCtD
Budesonide—Vision blurred—Methotrexate—bone cancer	0.00021	0.00168	CcSEcCtD
Budesonide—Mental disorder—Epirubicin—bone cancer	0.00021	0.00168	CcSEcCtD
Budesonide—Rash—Cisplatin—bone cancer	0.000209	0.00168	CcSEcCtD
Budesonide—Dermatitis—Cisplatin—bone cancer	0.000209	0.00167	CcSEcCtD
Budesonide—Malnutrition—Epirubicin—bone cancer	0.000208	0.00167	CcSEcCtD
Budesonide—Eye disorder—Doxorubicin—bone cancer	0.000207	0.00166	CcSEcCtD
Budesonide—Ill-defined disorder—Methotrexate—bone cancer	0.000207	0.00166	CcSEcCtD
Budesonide—Anaemia—Methotrexate—bone cancer	0.000206	0.00165	CcSEcCtD
Budesonide—Flushing—Doxorubicin—bone cancer	0.000205	0.00165	CcSEcCtD
Budesonide—Cardiac disorder—Doxorubicin—bone cancer	0.000205	0.00165	CcSEcCtD
Budesonide—Flatulence—Epirubicin—bone cancer	0.000205	0.00165	CcSEcCtD
Budesonide—Tension—Epirubicin—bone cancer	0.000204	0.00164	CcSEcCtD
Budesonide—Dysgeusia—Epirubicin—bone cancer	0.000204	0.00164	CcSEcCtD
Budesonide—Nervousness—Epirubicin—bone cancer	0.000202	0.00162	CcSEcCtD
Budesonide—Back pain—Epirubicin—bone cancer	0.000201	0.00162	CcSEcCtD
Budesonide—Angiopathy—Doxorubicin—bone cancer	0.000201	0.00161	CcSEcCtD
Budesonide—Malaise—Methotrexate—bone cancer	0.000201	0.00161	CcSEcCtD
Budesonide—Muscle spasms—Epirubicin—bone cancer	0.0002	0.00161	CcSEcCtD
Budesonide—Immune system disorder—Doxorubicin—bone cancer	0.0002	0.00161	CcSEcCtD
Budesonide—Vertigo—Methotrexate—bone cancer	0.0002	0.00161	CcSEcCtD
Budesonide—Mediastinal disorder—Doxorubicin—bone cancer	0.0002	0.0016	CcSEcCtD
Budesonide—Nausea—Cisplatin—bone cancer	0.000197	0.00158	CcSEcCtD
Budesonide—Vision blurred—Epirubicin—bone cancer	0.000196	0.00158	CcSEcCtD
Budesonide—Alopecia—Doxorubicin—bone cancer	0.000196	0.00157	CcSEcCtD
Budesonide—Cough—Methotrexate—bone cancer	0.000194	0.00156	CcSEcCtD
Budesonide—Mental disorder—Doxorubicin—bone cancer	0.000194	0.00156	CcSEcCtD
Budesonide—Ill-defined disorder—Epirubicin—bone cancer	0.000193	0.00155	CcSEcCtD
Budesonide—Malnutrition—Doxorubicin—bone cancer	0.000193	0.00155	CcSEcCtD
Budesonide—Anaemia—Epirubicin—bone cancer	0.000193	0.00155	CcSEcCtD
Budesonide—Hydrocortisone—CYP3A4—bone cancer	0.000192	0.0232	CrCbGaD
Budesonide—Agitation—Epirubicin—bone cancer	0.000191	0.00154	CcSEcCtD
Budesonide—Flatulence—Doxorubicin—bone cancer	0.00019	0.00153	CcSEcCtD
Budesonide—Myalgia—Methotrexate—bone cancer	0.000189	0.00152	CcSEcCtD
Budesonide—Arthralgia—Methotrexate—bone cancer	0.000189	0.00152	CcSEcCtD
Budesonide—Chest pain—Methotrexate—bone cancer	0.000189	0.00152	CcSEcCtD
Budesonide—Tension—Doxorubicin—bone cancer	0.000189	0.00152	CcSEcCtD
Budesonide—Dysgeusia—Doxorubicin—bone cancer	0.000189	0.00152	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000188	0.00151	CcSEcCtD
Budesonide—Malaise—Epirubicin—bone cancer	0.000188	0.00151	CcSEcCtD
Budesonide—Discomfort—Methotrexate—bone cancer	0.000187	0.0015	CcSEcCtD
Budesonide—Nervousness—Doxorubicin—bone cancer	0.000187	0.0015	CcSEcCtD
Budesonide—Vertigo—Epirubicin—bone cancer	0.000187	0.0015	CcSEcCtD
Budesonide—Syncope—Epirubicin—bone cancer	0.000187	0.0015	CcSEcCtD
Budesonide—Back pain—Doxorubicin—bone cancer	0.000186	0.0015	CcSEcCtD
Budesonide—Muscle spasms—Doxorubicin—bone cancer	0.000185	0.00149	CcSEcCtD
Budesonide—Palpitations—Epirubicin—bone cancer	0.000184	0.00148	CcSEcCtD
Budesonide—Confusional state—Methotrexate—bone cancer	0.000183	0.00147	CcSEcCtD
Budesonide—Loss of consciousness—Epirubicin—bone cancer	0.000183	0.00147	CcSEcCtD
Budesonide—Cough—Epirubicin—bone cancer	0.000182	0.00146	CcSEcCtD
Budesonide—Anaphylactic shock—Methotrexate—bone cancer	0.000182	0.00146	CcSEcCtD
Budesonide—Vision blurred—Doxorubicin—bone cancer	0.000182	0.00146	CcSEcCtD
Budesonide—Infection—Methotrexate—bone cancer	0.00018	0.00145	CcSEcCtD
Budesonide—Hypertension—Epirubicin—bone cancer	0.00018	0.00144	CcSEcCtD
Budesonide—Ill-defined disorder—Doxorubicin—bone cancer	0.000179	0.00144	CcSEcCtD
Budesonide—Nervous system disorder—Methotrexate—bone cancer	0.000178	0.00143	CcSEcCtD
Budesonide—Anaemia—Doxorubicin—bone cancer	0.000178	0.00143	CcSEcCtD
Budesonide—Myalgia—Epirubicin—bone cancer	0.000177	0.00142	CcSEcCtD
Budesonide—Arthralgia—Epirubicin—bone cancer	0.000177	0.00142	CcSEcCtD
Budesonide—Chest pain—Epirubicin—bone cancer	0.000177	0.00142	CcSEcCtD
Budesonide—Agitation—Doxorubicin—bone cancer	0.000177	0.00142	CcSEcCtD
Budesonide—Anxiety—Epirubicin—bone cancer	0.000177	0.00142	CcSEcCtD
Budesonide—Skin disorder—Methotrexate—bone cancer	0.000176	0.00142	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000176	0.00141	CcSEcCtD
Budesonide—Hyperhidrosis—Methotrexate—bone cancer	0.000176	0.00141	CcSEcCtD
Budesonide—Discomfort—Epirubicin—bone cancer	0.000175	0.00141	CcSEcCtD
Budesonide—Malaise—Doxorubicin—bone cancer	0.000174	0.0014	CcSEcCtD
Budesonide—Dry mouth—Epirubicin—bone cancer	0.000173	0.00139	CcSEcCtD
Budesonide—Vertigo—Doxorubicin—bone cancer	0.000173	0.00139	CcSEcCtD
Budesonide—Anorexia—Methotrexate—bone cancer	0.000173	0.00139	CcSEcCtD
Budesonide—Syncope—Doxorubicin—bone cancer	0.000173	0.00139	CcSEcCtD
Budesonide—Confusional state—Epirubicin—bone cancer	0.000171	0.00138	CcSEcCtD
Budesonide—Palpitations—Doxorubicin—bone cancer	0.00017	0.00137	CcSEcCtD
Budesonide—Anaphylactic shock—Epirubicin—bone cancer	0.00017	0.00137	CcSEcCtD
Budesonide—Loss of consciousness—Doxorubicin—bone cancer	0.000169	0.00136	CcSEcCtD
Budesonide—Infection—Epirubicin—bone cancer	0.000169	0.00136	CcSEcCtD
Budesonide—Cough—Doxorubicin—bone cancer	0.000168	0.00135	CcSEcCtD
Budesonide—Shock—Epirubicin—bone cancer	0.000167	0.00134	CcSEcCtD
Budesonide—Nervous system disorder—Epirubicin—bone cancer	0.000167	0.00134	CcSEcCtD
Budesonide—Hypertension—Doxorubicin—bone cancer	0.000166	0.00134	CcSEcCtD
Budesonide—Tachycardia—Epirubicin—bone cancer	0.000166	0.00133	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000165	0.00133	CcSEcCtD
Budesonide—Skin disorder—Epirubicin—bone cancer	0.000165	0.00133	CcSEcCtD
Budesonide—Hyperhidrosis—Epirubicin—bone cancer	0.000164	0.00132	CcSEcCtD
Budesonide—Insomnia—Methotrexate—bone cancer	0.000164	0.00132	CcSEcCtD
Budesonide—Chest pain—Doxorubicin—bone cancer	0.000164	0.00132	CcSEcCtD
Budesonide—Myalgia—Doxorubicin—bone cancer	0.000164	0.00132	CcSEcCtD
Budesonide—Arthralgia—Doxorubicin—bone cancer	0.000164	0.00132	CcSEcCtD
Budesonide—Anxiety—Doxorubicin—bone cancer	0.000164	0.00131	CcSEcCtD
Budesonide—Paraesthesia—Methotrexate—bone cancer	0.000163	0.00131	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000163	0.00131	CcSEcCtD
Budesonide—Discomfort—Doxorubicin—bone cancer	0.000162	0.0013	CcSEcCtD
Budesonide—Anorexia—Epirubicin—bone cancer	0.000162	0.0013	CcSEcCtD
Budesonide—Dyspnoea—Methotrexate—bone cancer	0.000162	0.0013	CcSEcCtD
Budesonide—Somnolence—Methotrexate—bone cancer	0.000161	0.0013	CcSEcCtD
Budesonide—Dry mouth—Doxorubicin—bone cancer	0.00016	0.00129	CcSEcCtD
Budesonide—Dyspepsia—Methotrexate—bone cancer	0.00016	0.00128	CcSEcCtD
Budesonide—Confusional state—Doxorubicin—bone cancer	0.000159	0.00127	CcSEcCtD
Budesonide—Decreased appetite—Methotrexate—bone cancer	0.000158	0.00127	CcSEcCtD
Budesonide—Anaphylactic shock—Doxorubicin—bone cancer	0.000157	0.00126	CcSEcCtD
Budesonide—Gastrointestinal disorder—Methotrexate—bone cancer	0.000157	0.00126	CcSEcCtD
Budesonide—Fatigue—Methotrexate—bone cancer	0.000157	0.00126	CcSEcCtD
Budesonide—Infection—Doxorubicin—bone cancer	0.000156	0.00126	CcSEcCtD
Budesonide—Pain—Methotrexate—bone cancer	0.000155	0.00125	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000155	0.00124	CcSEcCtD
Budesonide—Shock—Doxorubicin—bone cancer	0.000155	0.00124	CcSEcCtD
Budesonide—Nervous system disorder—Doxorubicin—bone cancer	0.000154	0.00124	CcSEcCtD
Budesonide—Insomnia—Epirubicin—bone cancer	0.000154	0.00123	CcSEcCtD
Budesonide—Tachycardia—Doxorubicin—bone cancer	0.000154	0.00123	CcSEcCtD
Budesonide—Skin disorder—Doxorubicin—bone cancer	0.000153	0.00123	CcSEcCtD
Budesonide—Paraesthesia—Epirubicin—bone cancer	0.000153	0.00123	CcSEcCtD
Budesonide—Hyperhidrosis—Doxorubicin—bone cancer	0.000152	0.00122	CcSEcCtD
Budesonide—Dyspnoea—Epirubicin—bone cancer	0.000152	0.00122	CcSEcCtD
Budesonide—Somnolence—Epirubicin—bone cancer	0.000151	0.00121	CcSEcCtD
Budesonide—Anorexia—Doxorubicin—bone cancer	0.00015	0.0012	CcSEcCtD
Budesonide—Feeling abnormal—Methotrexate—bone cancer	0.00015	0.0012	CcSEcCtD
Budesonide—Dyspepsia—Epirubicin—bone cancer	0.00015	0.0012	CcSEcCtD
Budesonide—Gastrointestinal pain—Methotrexate—bone cancer	0.000149	0.00119	CcSEcCtD
Budesonide—Decreased appetite—Epirubicin—bone cancer	0.000148	0.00119	CcSEcCtD
Budesonide—Gastrointestinal disorder—Epirubicin—bone cancer	0.000147	0.00118	CcSEcCtD
Budesonide—Fatigue—Epirubicin—bone cancer	0.000147	0.00118	CcSEcCtD
Budesonide—Constipation—Epirubicin—bone cancer	0.000145	0.00117	CcSEcCtD
Budesonide—Pain—Epirubicin—bone cancer	0.000145	0.00117	CcSEcCtD
Budesonide—Urticaria—Methotrexate—bone cancer	0.000144	0.00116	CcSEcCtD
Budesonide—Abdominal pain—Methotrexate—bone cancer	0.000144	0.00115	CcSEcCtD
Budesonide—Body temperature increased—Methotrexate—bone cancer	0.000144	0.00115	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000143	0.00115	CcSEcCtD
Budesonide—Dexamethasone—CYP3A4—bone cancer	0.000143	0.0173	CrCbGaD
Budesonide—Insomnia—Doxorubicin—bone cancer	0.000142	0.00114	CcSEcCtD
Budesonide—Paraesthesia—Doxorubicin—bone cancer	0.000141	0.00113	CcSEcCtD
Budesonide—Dexamethasone—PTGS2—bone cancer	0.00014	0.0169	CrCbGaD
Budesonide—Dyspnoea—Doxorubicin—bone cancer	0.00014	0.00113	CcSEcCtD
Budesonide—Feeling abnormal—Epirubicin—bone cancer	0.00014	0.00113	CcSEcCtD
Budesonide—Somnolence—Doxorubicin—bone cancer	0.00014	0.00112	CcSEcCtD
Budesonide—Gastrointestinal pain—Epirubicin—bone cancer	0.000139	0.00112	CcSEcCtD
Budesonide—Dyspepsia—Doxorubicin—bone cancer	0.000138	0.00111	CcSEcCtD
Budesonide—Decreased appetite—Doxorubicin—bone cancer	0.000137	0.0011	CcSEcCtD
Budesonide—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000136	0.00109	CcSEcCtD
Budesonide—Fatigue—Doxorubicin—bone cancer	0.000136	0.00109	CcSEcCtD
Budesonide—Urticaria—Epirubicin—bone cancer	0.000135	0.00108	CcSEcCtD
Budesonide—Pain—Doxorubicin—bone cancer	0.000134	0.00108	CcSEcCtD
Budesonide—Constipation—Doxorubicin—bone cancer	0.000134	0.00108	CcSEcCtD
Budesonide—Abdominal pain—Epirubicin—bone cancer	0.000134	0.00108	CcSEcCtD
Budesonide—Body temperature increased—Epirubicin—bone cancer	0.000134	0.00108	CcSEcCtD
Budesonide—Hypersensitivity—Methotrexate—bone cancer	0.000134	0.00107	CcSEcCtD
Budesonide—Asthenia—Methotrexate—bone cancer	0.00013	0.00105	CcSEcCtD
Budesonide—Feeling abnormal—Doxorubicin—bone cancer	0.00013	0.00104	CcSEcCtD
Budesonide—Gastrointestinal pain—Doxorubicin—bone cancer	0.000129	0.00103	CcSEcCtD
Budesonide—Pruritus—Methotrexate—bone cancer	0.000129	0.00103	CcSEcCtD
Budesonide—Hypersensitivity—Epirubicin—bone cancer	0.000125	0.00101	CcSEcCtD
Budesonide—Urticaria—Doxorubicin—bone cancer	0.000125	0.001	CcSEcCtD
Budesonide—Abdominal pain—Doxorubicin—bone cancer	0.000124	0.000999	CcSEcCtD
Budesonide—Body temperature increased—Doxorubicin—bone cancer	0.000124	0.000999	CcSEcCtD
Budesonide—Diarrhoea—Methotrexate—bone cancer	0.000124	0.000998	CcSEcCtD
Budesonide—Asthenia—Epirubicin—bone cancer	0.000122	0.00098	CcSEcCtD
Budesonide—Pruritus—Epirubicin—bone cancer	0.00012	0.000966	CcSEcCtD
Budesonide—Dizziness—Methotrexate—bone cancer	0.00012	0.000965	CcSEcCtD
Budesonide—Diarrhoea—Epirubicin—bone cancer	0.000116	0.000934	CcSEcCtD
Budesonide—Hypersensitivity—Doxorubicin—bone cancer	0.000116	0.000931	CcSEcCtD
Budesonide—Vomiting—Methotrexate—bone cancer	0.000115	0.000928	CcSEcCtD
Budesonide—Rash—Methotrexate—bone cancer	0.000115	0.00092	CcSEcCtD
Budesonide—Dermatitis—Methotrexate—bone cancer	0.000114	0.000919	CcSEcCtD
Budesonide—Headache—Methotrexate—bone cancer	0.000114	0.000914	CcSEcCtD
Budesonide—Asthenia—Doxorubicin—bone cancer	0.000113	0.000906	CcSEcCtD
Budesonide—Dizziness—Epirubicin—bone cancer	0.000112	0.000903	CcSEcCtD
Budesonide—Pruritus—Doxorubicin—bone cancer	0.000111	0.000894	CcSEcCtD
Budesonide—Vomiting—Epirubicin—bone cancer	0.000108	0.000868	CcSEcCtD
Budesonide—Nausea—Methotrexate—bone cancer	0.000108	0.000867	CcSEcCtD
Budesonide—Diarrhoea—Doxorubicin—bone cancer	0.000108	0.000864	CcSEcCtD
Budesonide—Rash—Epirubicin—bone cancer	0.000107	0.000861	CcSEcCtD
Budesonide—Dermatitis—Epirubicin—bone cancer	0.000107	0.00086	CcSEcCtD
Budesonide—Headache—Epirubicin—bone cancer	0.000106	0.000855	CcSEcCtD
Budesonide—Dizziness—Doxorubicin—bone cancer	0.000104	0.000835	CcSEcCtD
Budesonide—Nausea—Epirubicin—bone cancer	0.000101	0.000811	CcSEcCtD
Budesonide—Vomiting—Doxorubicin—bone cancer	0.0001	0.000803	CcSEcCtD
Budesonide—Rash—Doxorubicin—bone cancer	9.92e-05	0.000797	CcSEcCtD
Budesonide—Dermatitis—Doxorubicin—bone cancer	9.91e-05	0.000796	CcSEcCtD
Budesonide—Headache—Doxorubicin—bone cancer	9.85e-05	0.000791	CcSEcCtD
Budesonide—Nausea—Doxorubicin—bone cancer	9.34e-05	0.00075	CcSEcCtD
